Francis R. Spitz
- Oncology top 2%
- Surgery top 5%
- Cancer Research top 5%
- Pathology and Forensic Medicine top 2%
- Molecular Biology
- Co-authors
- Douglas L. FrakerBrian J. CzernieckiIsabelle BedrosianLinda S. CallansRosemarie MickDavid E. ElderSusan G. OrelCarol Reynolds
- Topics
- Cutaneous Melanoma Detection and Management (8 papers)Virus-based gene therapy research (7 papers)Breast Lesions and Carcinomas (7 papers)
- Journals
- Journal of the American Chemical SocietyJournal of Clinical InvestigationJournal of Clinical Oncology
- Partner nations
- United StatesIndiaUnited Kingdom
In The Last Decade
Francis R. Spitz
53 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 116
- Oncology 1.1k
- Surgery 542
- Cancer Research 530
- Pathology and Forensic Medicine 522
- Molecular Biology 493
Countries citing papers authored by Francis R. Spitz
This map shows the geographic impact of Francis R. Spitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francis R. Spitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francis R. Spitz more than expected).
Fields of papers citing papers by Francis R. Spitz
This network shows the impact of papers produced by Francis R. Spitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francis R. Spitz. The network helps show where Francis R. Spitz may publish in the future.
Co-authorship network of co-authors of Francis R. Spitz
This figure shows the co-authorship network connecting the top 25 collaborators of Francis R. Spitz. A scholar is included among the top collaborators of Francis R. Spitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francis R. Spitz. Francis R. Spitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 3 | |
| 3 | 10 | |
| 4 | 1 | |
| 5 | 22 | |
| 6 | 107 | |
| 7 | 139 | |
| 8 | 23 | |
| 9 | 89 | |
| 10 | 12 | |
| 11 | 9 | |
| 12 | 167 | |
| 13 | 27 | |
| 14 | 264 | |
| 15 | 75 | |
| 16 | 17 | |
| 17 | 16 | |
| 18 | 10 | |
| 19 | 35 | |
| 20 | 108 |
About Francis R. Spitz
Francis R. Spitz is a scholar working on Oncology, Health Informatics and Pathology and Forensic Medicine, having authored 55 papers that have together received 2.4k indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (8 papers), Virus-based gene therapy research (7 papers) and Breast Lesions and Carcinomas (7 papers). The work is most often cited by research in Oncology (1.1k citations), Cancer Research (530 citations) and Pathology and Forensic Medicine (522 citations). Francis R. Spitz has collaborated with scholars based in United States, India and United Kingdom. Frequent co-authors include Douglas L. Fraker, Brian J. Czerniecki, Isabelle Bedrosian, Linda S. Callans, Rosemarie Mick, David E. Elder, Susan G. Orel, Carol Reynolds, Michael E. Ming and Phyllis A. Gimotty. Their work appears in journals such as Journal of the American Chemical Society, Journal of Clinical Investigation and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.